Results 181 to 190 of about 4,695 (214)
Some of the next articles are maybe not open access.
Hemolytic Disease of the Fetus and Newborn
2016Hemolytic disease of the fetus and newborn (HDFN) is a condition that results in varying degrees of hyperbilirubinemia and anemia. The diseases that produce this condition are broadly categorized as isoimmune (antibody mediated) or non-isoimmune.
Sara C. Handley, Michael A. Posencheg
openaire +1 more source
Hemolytic Disease of the Fetus and Newborn
Clinics in Laboratory Medicine, 2021Melanie E. Jackson, Jillian M. Baker
openaire +2 more sources
Hemolytic disease of the fetus and newborn in the molecular era
Seminars in Fetal and Neonatal Medicine, 2016Maternal-fetal red cell antigen incompatibility can lead to alloimmunization, maternal immunoglobulin transplacental transfer, and hemolytic disease of the fetus and newborn (HDFN). The use of routine antenatal anti-D prophylaxis (RAADP) has sharply decreased the incidence of and mortality from HDFN due to RhD allosensitization. The ability to identify
openaire +2 more sources
Prenatal testing to predict the severity of hemolytic disease of the fetus and newborn
Current Opinion in Hematology, 1996The severity of hemolytic disease of the fetus or newborn can be assessed with certainty only by measurement of fetal parameters. However, these invasive procedures are not without risk for the fetus. Most erythrocyte antibodies do not cause significant hemolytic disease of the fetus or newborn and various assays are available to assist obstetricians ...
M, Contreras, S F, Garner, M, de Silva
openaire +2 more sources
HEMOLYTIC DISEASE OF THE FETUS AND THE NEWBORN INFANT
American Journal of Diseases of Children, 1944The Rh factor of Landsteiner and Wiener1has been shown to be related to about 90 per cent of the reactions to intragroup blood transfusion2and to about 90 per cent of the cases of erythroblastosis (hemolytic disease of the fetus and of the newborn).3 In the typical case, the patient having a hemolytic reaction to an intragroup transfusion or the ...
openaire +1 more source
Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations
Transfusion Medicine Reviews, 2016Red blood cell (RBC) sensitization occurs in some women in response to exposure to paternally derived RBC antigens during pregnancy or to nonself antigens on transfused RBCs during their lifetime. Once sensitized, future pregnancies may be at risk for hemolytic disease of the fetus and newborn.
Jeanne E, Hendrickson, Meghan, Delaney
openaire +2 more sources
Hemolytic disease of the fetus and newborn caused by anti‐
BackgroundAntibodies to the high‐incidence red blood cell (RBC) antigen Lan (Langereis) are typically immunoglobulin G and have been shown to fix complement and cause hemolysis of Lan antigen–positive RBCs. Only three cases of hemolytic disease of the fetus and newborn (HDFN) have been reported involving anti‐Lan and all have been characterized as ...
Sarah, Brooks, Jerry E, Squires
openaire +2 more sources
Consensus in prenatal management of Hemolytic disease of the fetus and newborn
Best Practice & Research Clinical Obstetrics & GynaecologyHemolytic Disease of the Fetus and Newborn (HDFN) is complication caused by maternal alloantibodies crossing the placenta and leading to the destruction of fetal red blood cells. While RhD is the most common antigen causing HDFN, Kell alloimmunization is the most severe. The assessment of HDFN risk begins with identifying the fetal antigen status.
Brittany Jill Arkerson +2 more
openaire +2 more sources
Mouse Model of Hemolytic Disease of the Fetus and Newborn
Hemolytic Disease of the Fetus and Newborn (HDFN) is caused by the placental transfer of maternal red blood cell (RBC) alloantibodies into the fetal circulation which then targets paternally derived RBC antigens expressed on the fetal RBC. The resulting anemia in the fetus/newborn can lead to grave clinical consequences including hydrops fetalis ...Hirotomo, Nakahara +4 more
openaire +2 more sources

